References

Evolving payer coverage policies on genomic sequencing tests: beginning of the end or end of the beginning?

10.1001/jama.2018.4863 · 2018 · External reference

Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy.

10.1093/haschl/qxad005 · 2023 · External reference

Implementation of cancer genomics in the United States: views of payers and other stakeholders on challenges and the role of payers in solutions.

10.1200/po-24-00822 · 2025 · External reference

Why evidence generation should matter to payers and how they can help.

10.1001/jama.2024.7616 · 2024 · External reference

Decision making on medical innovations in a changing health care environment: insights from accountable care organizations and payers on personalized medicine and other technologies.

10.1016/j.jval.2016.09.2402 · 2017 · External reference

Precision medicine: from science to value.

10.1377/hlthaff.2017.1624 · 2018 · External reference

The state of state biomarker testing insurance coverage laws.

10.1001/jama.2024.6058 · 2024 · External reference

Financial assistance programs for genetic testing: effective, ethical, and sustainable pathways to improving access disparities?

10.1016/j.gim.2025.101417 · 2025 · External reference

Multicancer screening tests: anticipating and addressing considerations for payer coverage and patient access.

10.1377/hlthaff.2021.01316 · 2022 · External reference

Unresolved reference

External reference